| Secondary |
| Supplementation Therapy |
22.3% |
| Pancreatitis |
10.3% |
| Hypertension |
6.0% |
| Sedation |
5.4% |
| Thrombosis Prophylaxis |
5.4% |
| Drug Use For Unknown Indication |
4.9% |
| Tuberculosis |
4.3% |
| Acne |
3.3% |
| Alcohol Detoxification |
3.3% |
| Constipation |
3.3% |
| Ear Infection |
3.3% |
| Nausea |
3.3% |
| Pain |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Prophylaxis |
3.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.3% |
| Sepsis |
3.3% |
| Withdrawal Syndrome |
3.3% |
| Alcohol Withdrawal Syndrome |
2.7% |
| Pyrexia |
2.7% |
|
| Toxic Epidermal Necrolysis |
16.7% |
| Arrhythmia |
8.3% |
| Cytolytic Hepatitis |
8.3% |
| Hypoacusis |
8.3% |
| Multi-organ Failure |
8.3% |
| Rash Morbilliform |
8.3% |
| Sputum Increased |
8.3% |
| Cough |
4.2% |
| Delirium |
4.2% |
| Gastroenteritis Viral |
4.2% |
| Hepatitis Alcoholic |
4.2% |
| Neutropenia |
4.2% |
| Pruritus |
4.2% |
| Weight Decreased |
4.2% |
| Weight Increased |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.5% |
| Drug Use For Unknown Indication |
13.6% |
| Prophylaxis |
13.3% |
| Hypertension |
5.6% |
| Supplementation Therapy |
4.6% |
| Depression |
3.8% |
| Pain |
3.6% |
| Vitamin Supplementation |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Hiv Infection |
2.3% |
| Blood Cholesterol Increased |
2.2% |
| Osteoporosis |
1.8% |
| Diabetes Mellitus |
1.7% |
| Multiple Myeloma |
1.6% |
| Intervertebral Disc Protrusion |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Anxiety |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Head And Neck Cancer |
1.4% |
| Sepsis |
1.4% |
|
| Vomiting |
10.6% |
| White Blood Cell Count Decreased |
9.9% |
| Weight Decreased |
9.2% |
| Pyrexia |
7.0% |
| Somnolence |
5.6% |
| Urinary Tract Infection |
4.9% |
| Cytolytic Hepatitis |
4.2% |
| Drug Ineffective |
4.2% |
| Mesenteric Vein Thrombosis |
4.2% |
| Thrombocytopenia |
4.2% |
| Treatment Noncompliance |
4.2% |
| Anxiety |
3.5% |
| Convulsion |
3.5% |
| Dizziness |
3.5% |
| Fall |
3.5% |
| Granulocytopenia |
3.5% |
| Oedema Peripheral |
3.5% |
| Pain In Extremity |
3.5% |
| Toxic Epidermal Necrolysis |
3.5% |
| Urticaria |
3.5% |
|
| Interacting |
| Malignant Melanoma |
100.0% |
|
|
